Despite beating Q2 estimates with 9% organic growth, Stryker's stock fell 9% as investors questioned cyber recovery and ...

Independent laboratory data and engineering insights to support EM tracking technology and supplier evaluations.

The investment strengthens Atlantia’s US clinical operations as device manufacturers seek faster, more cost-effective ...

Quasar Medical, a global contract development and manufacturing organization (CDMO) specializing in minimally invasive medical devices, announced the acquisition of the Medres' Nitinol Design and ...

Each year, the medical device industry has highs and lows. And each year, MD+DI editors take the time to look at the companies and segments of the industry that have the biggest gains and the biggest ...

Boston Scientific approved a restructuring plan that could reduce expenses by about $500 million a year and lead to the ...

Philips posts 4% Q2 sales growth but relies on EUR 186M tariff refund to boost margins by 4.2 points. Stock falls 9% on China ...

For life sciences executives evaluating digital health portfolios, anatomically informed architectures represent a defensible ...

The surgical robotics company will wind down operations and liquidate assets after running out of cash to continue ...

Trump imposes 10-12.5% tariffs on 60 trade partners over forced labor claims, covering 99.4% of imports including medical ...

Lindsey Dinneen tackles a critical truth: great ideas fail every day in medtech — not because they lack merit, but because ...

Boston Scientific confirmed investors' worst fears Wednesday by cutting 2026 guidance for the second time this year. “This update today is not the outcome we planned or what you have come to expect ...